Gene- and Cell-Based Therapies Entering Glaucoma Trials in April 2026
Some trials deliver genes encoding neuroprotective factors into the eye to help RGCs survive. For example, one approach uses a harmless viral vector...
Deep research and expert guides on maintaining your visual health.
Some trials deliver genes encoding neuroprotective factors into the eye to help RGCs survive. For example, one approach uses a harmless viral vector...
Visual field loss from conditions like glaucoma can go unnoticed. Start a free trial and screen for potential blind spots in minutes.
A sham control is a deliberately inactive procedure used in a clinical study to mimic a real treatment without giving the therapeutic element. Itโs most common in trials of surgeries, devices, or procedures where a sugar pill would not fool participants; the sham looks and feels like the real intervention so patients and sometimes clinicians remain unaware who got the actual treatment. This keeps expectations and the placebo effect balanced between groups, which helps researchers learn whether the real procedure truly works beyond psychological or observational bias. Sham controls matter because they make trial results more reliable, especially when outcomes depend on patient-reported symptoms or subjective measures. Using a sham raises ethical questions because it exposes people to risk without possible direct benefit, so studies must minimize harm, offer clear consent, and justify why a sham is needed. When done carefully, sham-controlled research can prevent ineffective or harmful procedures from becoming widely used and can speed adoption of genuinely helpful innovations.